Clinical Trials Browser

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Urinary Bladder Neoplasms, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Kidney Neoplasms, Melanoma, Stomach Neoplasms, Colorectal Neoplasms, Carcinoma, Merkel Cell, Cholangiocarcinoma

NCT03013010 2025-12-08

PREACT

Phase 3 Completed

204 enrolled

Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

NCT03813784 2025-09-16

A Clinical Study To Evaluate Camrelizumab (SHR-1210) Plus Capecitabine and Oxaliplatin Followed by Sequential Treatment With Camrelizumab Plus Apatinib Mesylate in Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJ) Without Prior Systemic Therapy

Phase 3 Completed

885 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02872116 2025-08-07

CheckMate649

Phase 3 Completed

2,031 enrolled 19 charts 2 FDA

Gastrointestinal

Adenocarcinoma Of Esophagus, Stomach Neoplasms

NCT06793917 2025-07-20

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 3 Recruiting

269 enrolled

Gastrointestinal

Stomach Neoplasms

NCT03348150 2025-07-17

PERISCOPEII

Phase 3 Active not recruiting

102 enrolled

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT06949033 2025-07-10

Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 3 Recruiting

668 enrolled

Gastrointestinal

Stomach Neoplasms

NCT01815853 2025-07-03

Neo-CRAG

Phase 3 Completed

620 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06939439 2025-07-01

Using ctDNA to Guide Treatment Decisions for Stage III Gastric Cancer

Phase 3 Active not recruiting

416 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06768164 2025-05-14

BYQoL-GC

Phase 3 Not yet recruiting

250 enrolled

Gastrointestinal

Neoplasms, Stomach Neoplasms

NCT04032119 2025-05-04

RCT of Gastric ESD With or Without Epineprhine Added Solution

Phase 3 Completed

800 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06944496 2025-04-25

A Study of Disitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Phase 3 Not yet recruiting

616 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06925243 2025-04-22

Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined With Perioperative SOX for Intestinal Type of Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

Phase 3 Recruiting

682 enrolled

Gastrointestinal

Stomach Neoplasms

NCT05593458 2025-04-09

TACTIC

Phase 3 Recruiting

190 enrolled

Gastrointestinal

Stomach Neoplasms

NCT06755554 2025-03-30

ICGastr

Phase 3 Recruiting

105 enrolled

Gastrointestinal

Stomach Neoplasms

NCT02349412 2025-02-07

Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers

Phase 3 Completed

405 enrolled 11 charts

GastrointestinalOther solid neoplasmThoracic

Mesothelioma, Malignant, Anxiety Disorders, Bile Duct Neoplasms, Carcinoma, Non-Small-Cell Lung, Depression, Esophageal Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

NCT02112214 2024-12-27